Martine A Rothblatt - Net Worth and Insider Trading
Martine A Rothblatt Net Worth
The estimated net worth of Martine A Rothblatt is at least $17 Million dollars as of 2024-11-29. Martine A Rothblatt is the Chairperson & CEO of United Therapeutics Corp and owns about 45,892 shares of United Therapeutics Corp (UTHR) stock worth over $17 Million. Details can be seen in Martine A Rothblatt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martine A Rothblatt has not made any transactions after 2024-08-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Martine A Rothblatt
Martine A Rothblatt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martine A Rothblatt owns 1 companies in total, including United Therapeutics Corp (UTHR) .
Click here to see the complete history of Martine A Rothblatt’s form 4 insider trades.
Insider Ownership Summary of Martine A Rothblatt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| UTHR | United Therapeutics Corp | 2024-08-26 | director & Chief Executive Officer |
Martine A Rothblatt Latest Holdings Summary
Martine A Rothblatt currently owns a total of 1 stock. Martine A Rothblatt owns 45,892 shares of United Therapeutics Corp (UTHR) as of August 26, 2024, with a value of $17 Million.
Latest Holdings of Martine A Rothblatt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| UTHR | United Therapeutics Corp | 2024-08-26 | 45,892 | 378.13 | 17,353,142 |
Holding Weightings of Martine A Rothblatt
Martine A Rothblatt Form 4 Trading Tracker
According to the SEC Form 4 filings, Martine A Rothblatt has made a total of 154 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 154 sells. The most-recent trade in United Therapeutics Corp is the sale of 269 shares on August 26, 2024, which brought Martine A Rothblatt around $93,722.
Insider Trading History of Martine A Rothblatt
- 1
Martine A Rothblatt Trading Performance
GuruFocus tracks the stock performance after each of Martine A Rothblatt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martine A Rothblatt is 16.94%. GuruFocus also compares Martine A Rothblatt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martine A Rothblatt within 3 months outperforms 17 times out of 21 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martine A Rothblatt's insider trading performs compared to the benchmark.
Performance of Martine A Rothblatt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.91 | | | | | |
| Relative Return to S&P 500(%) | 6.42 | | | | | |
Martine A Rothblatt Ownership Network
Martine A Rothblatt Owned Company Details
What does United Therapeutics Corp do?
Who are the key executives at United Therapeutics Corp?
Martine A Rothblatt is the director & Chief Executive Officer of United Therapeutics Corp. Other key executives at United Therapeutics Corp include President and COO Michael Benkowitz , EVP & General Counsel Paul A Mahon , and CFO and Treasurer James Edgemond .
United Therapeutics Corp (UTHR) Insider Trades Summary
Over the past 18 months, Martine A Rothblatt made 64 insider transaction in United Therapeutics Corp (UTHR) with a net sale of 707,954. Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 130,200 shares made by Paul A Mahon , a net sale of 133,718 shares made by James Edgemond , and a net sale of 14,360 shares made by Christopher Causey .
In summary, during the past 3 months, insiders sold 177,815 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 177,815 shares. During the past 18 months, 1,143,835 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,143,835 shares.
United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.
United Therapeutics Corp Insider Transactions
Martine A Rothblatt Mailing Address
Above is the net worth, insider trading, and ownership report for Martine A Rothblatt. Currently GuruFocus does not have mailing address information for Martine A Rothblatt.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
